Apollon Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Apollon Wealth Management, LLC

$3.45 Billion
Q3 2024

A detailed history of Apollon Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 1,592 shares of REGN stock, worth $1.24 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,592

Previous 1,675 4.96%

Holding current value

$1.24 Million

Previous $1.76 Million 4.94%

% of portfolio

0.05%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$1024.09 - $1201.76 $84,999 - $99,746	-83 Reduced 4.96%	1,592 $1.67 Million
Q2 2024 Jul 19, 2024	SELL	$883.2 - $1071.19 $26,496 - $32,135	-30 Reduced 1.76%	1,675 $1.76 Million
Q1 2024 May 02, 2024	BUY	$902.69 - $993.35 $377,324 - $415,220	418 Added 32.48%	1,705 $1.64 Million
Q4 2023 Feb 06, 2024	BUY	$775.18 - $881.7 $243,406 - $276,853	314 Added 32.27%	1,287 $1.13 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $42,931 - $52,350	62 Added 6.81%	973 $800,000
Q2 2023 Aug 04, 2023	BUY	$700.03 - $830.35 $105,704 - $125,382	151 Added 19.87%	911 $654,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $27,219 - $33,078	-40 Reduced 5.0%	760 $624,000
Q4 2022 Feb 15, 2023	SELL	$705.89 - $766.39 $396,710 - $430,711	-562 Reduced 41.26%	800 $577,000
Q3 2022 Nov 08, 2022	BUY	$573.97 - $724.32 $63,136 - $79,675	110 Added 8.79%	1,362 $938,000
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $37,287 - $50,241	-68 Reduced 5.15%	1,252 $740,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $17,853 - $20,952	-30 Reduced 2.22%	1,320 $922,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $70,652 - $87,226	130 Added 10.66%	1,350 $853,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $144,081 - $170,920	-251 Reduced 17.06%	1,220 $738,000
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $150,350 - $177,615	-318 Reduced 17.78%	1,471 $822,000
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $799,199 - $980,729	1,789 New	1,789 $846,000
Q3 2020 Nov 03, 2020	SELL	$544.75 - $658.21 $8,716 - $10,531	-16 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $7,893 - $10,302	16 New	16 $10,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.

Account

Apollon Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History